Linden Capital L.P. 13D and 13G filings for TRACON Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-27 4:03 pm Unchanged |
2021-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Linden Capital L.P. | 46,080 4.600% |
0 (Unchanged) |
Filing |
| 2021-02-09 3:17 pm Purchase |
2020-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Linden Capital L.P. | 46,080 6.000% |
46,080 (New Position) |
Filing |